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Remotecontrolofaptamerfunctionhasallowedustocontrolproteinfunctioninspaceandtime.Here,weproposeanovelcontrol
system for aptamer function by radiofrequency magnetic ﬁeld- (RFMF-) induced local heating of a gold nanoparticle conjugated
with an aptamer. In this study, we used a 31-mer thrombin-binding aptamer (TBA), which can inhibit thrombin activity, as a
model aptamer. We evaluated the RFMF control of the inhibitory activity of a gold nanoparticle-conjugated TBA. To evaluate the
eﬀect of RFMF on enzymatic activity, we utilized a complementary DNA strand that maintains the broken structure during the
activity assay. We observed a decrease in the inhibitory activity of TBA after RFMF irradiation. It indicates that RFMF is capable of
controlling the TBA structure. Because RFMF allows noninvasive control of aptamer function, this strategy is expected to be novel
way of controlling aptamer drug activity.
1.Introduction
Aptamers, single-stranded DNA or RNA molecules, recog-
nize various target molecules on forming a particular three-
dimensional structure [1, 2]. Each aptamer has a diﬀerent
topology and three-dimensional structure that recognizes a
target [3]. Although most proteins lose their function by
denaturing their structure irreversibly, aptamers can form
correct structures reversibly even after denaturation of their
structure. Therefore, aptamer function can be controlled
reversibly by controlling the structures.
Many researchers have reported the remote control of
functional nucleic acids by UV light irradiation. Caged
compounds, which can be controlled by light, have been
utilized for the remote control of aptamers and siRNA
[4, 5]. However, because only a small amount of UV light
penetrates deep tissues and also damages DNA structure,
the application of UV light would be limited unless speciﬁc
devices are used that generate two-photon absorption [6].
Hamad-Schﬀeril et al. have reported remote electronic
control of the DNA structure by inductive coupling of a
radiofrequency magnetic ﬁeld to a metal nanocrystal coval-
ently linked to DNA [7]. Gold nanoparticles were heated
by irradiation of a radiofrequency magnetic ﬁeld (RFMF),
leadingtodenaturationofaDNAandleavesthesurrounding
molecules relatively unaﬀected.
In this study, we propose a novel system for controlling
aptamer function by RFMF irradiation (Figure 1). Local
heating of a gold nanoparticle by RFMF irradiation would
destabilize the aptamer structure and result in a decrease in
aptamer function. However, the aptamer can easily refold
to its native structure after denaturation of its structure.
To evaluate their function easily, we introduced a com-
plementary DNA strand that would not aﬀect aptamer2 Journal of Nucleic Acids
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Figure 1: The scheme for the controlling of the function of gold nanoparticle-conjugated thrombin-inhibiting aptamer by RFMF.
function in the absence of RFMF irradiation. We expect
that the complementary DNA strand hybridizes the aptamer
on RFMF irradiation and remains in the hybridized state
even after RFMF irradiation. Because the complementary
DNA would help repress the refolding of the aptamer to its
native structure, we can easily evaluate the aptamer function
activity after RFMF irradiation.
In this study, we selected thrombin-binding aptamer
(TBA) as a model aptamer. TBA forms a G-quadruplex
structure to inhibit thrombin activity [8]. We selected a
31-mer TBA, because it has higher inhibitory activity than
the more commonly used 15-mer TBA [9, 10]. In addition,
because the 31-mer TBA forms the G-quadruplex structure
attached to the stem region, we expect that conjugation of
the gold nanoparticle has little eﬀect on thrombin inhibitory
activity of TBA. We prepared a 31-mer TBA conjugated with
a gold nanoparticle (Au-TBA) and examined the control of
its function by RFMF irradiation.
2.MaterialsandMethods
2.1. Linkage of Gold Nanocrystals to TBA. Am o n o m a l e i m -
ide-modiﬁed gold nanoparticle (diameter, 1.4nm) was pur-
chased from Nanoprobes (NY, USA). The DNA was synthe-
sized by Operon Biotechnologies (Tokyo, Japan). The 5  end
of the 31-mer TBA (5 -CACTGGTAGGTTGGTGTGGTT-
GGGGCCAGTG-3 ) was thiolated. A gold nanoparticle-
conjugated 31-mer TBA was prepared according to the
procedurepublishedintheliterature[7].Aftergoldnanopar-
ticles were prepared with 10% isopropanol and diluted
with water, a thiolated 31-mer thrombin-inhibiting aptamer
(3nmol) was coupled with an excess of monomaleimide-
gold nanoparticles (30nmol) at 4◦C for 24h. A gold
nanoparticle-conjugated TBA was puriﬁed by Superdex 75
HiLoad 16/60 (GE Healthcare, UK Ltd, Buckinghamshire,
England) in 5mM NaH2PO4, 150mM NaCl (pH 6.5).
Successful conjugation of gold nanoparticles with TBA
(Au-TBA) was veriﬁed by native polyacrylamide gel (11%)
electrophoresis (PAGE) in TBE buﬀer (89mM Tris, 89mM
H3BO3,2m ME D T A )a tr o o mt e m p e r a t u r e .T h eb a n ds i z e
of Au-TBA was compared with the ﬂuorescein-modiﬁed 31-
merTBA.Fluorescein-modiﬁed31-merTBAwasdetectedby
a Typhoon 8600 (GE Healthcare, UK Ltd, Buckinghamshire,
England) and Au-TBA was visualized by LI Silver staining
(Nanoprobes, NY, USA) for 5min to conﬁrm Au-TBA
puriﬁcation.
2.2. Au-TBA Characterization. In TBS buﬀer (50mM Tris-
HCl (pH 8.0), 100mM NaCl, 5mM KCl), Au-TBA (ﬁnal
concentration, 100nM) and 13.5-nM thrombin (Wako
Chemicals, Osaka, Japan) were mixed at room temperature
for 5min. Then, 2mg/mL ﬁbrinogen (Wako Chemicals,
Osaka, Japan) was mixed, and the clotting time was mea-
sured using Amelung KC-4A Micro Coagulation Analyzer
(RWTUV, Essen, Germany) at 37◦C.
2.3. Evaluation of Complementary DNA to Control Au-TBA
Inhibitory Activity. Each complementary DNA (Table 1)
(100nM) was mixed with Au-TBA (100nM) and thrombin
(13.5nM). Mixtures were incubated at room temperature
for 5min and then mixed with ﬁbrinogen (2mg/mL). The
clotting time was measured using Amelung KC-4A Micro
Coagulation Analyzer at 37◦C.
2.4. Control of the Inhibitory Activity of Au-TBA by
RFMF. Au-TBA(100nM)and20-mercomplementaryDNA
(100nM) and thrombin (13.5nM) were incubated for 30s
at room temperature in 50mM Tris-HCl (pH 8.0), 100mM
NaCl, 5mM KCl and were irradiated by RFMF (1GHz,Journal of Nucleic Acids 3
Table 1
Name Sequence Tm value (◦C)∗
TBA 5 -CACTGGTAGGTTGGTGTGGTTGGGGCCAGTG-3  64
14-mer 5 -CACTGGCCCCAACC-3  52.2
15-mer 5 -CACTGGCCCCAACCA-3  54.2
16-mer 5 -CACTGGCCCCAACCAC-3  56.4
17-mer 5 -CACTGGCCCCAACCACA-3  58
20-mer 5 -CACTGGCCCCAACCACACCA-3  63.3
23-mer 5 -CACTGGCCCCAACCACACCAACC-3  66.7
∗Tm (melting temperature) values of complementary DNA were predicted using mfold program. Tm value of TBA was measured using UV melting assay.
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Figure 2: Evaluation of the eﬀe c to fR F M Fo nt h r o m b i na c t i v i t y .
Mixtures of Au-TBA and thrombin were irradiated for 5min,
15min, or 30min. As control, the mixtures were incubated for the
same time at room temperature. Fibrinogen was added, and then,
the clotting time was measured. White bars show clotting times
without RFMF irradiation. Black bars show clotting times with
RFMF irradiation.
1.5W) for 5min by using an HP 8648C RF signal generator
(Hewlett-Packard Company, Calif, USA). The diameter of
a coil was 1cm and its height was 5cm with 35 turns. To
optimize RFMF power, we connected a tuning horn to an
ampliﬁer for matching. Then, ﬁbrinogen (2mg/mL) was
mixed, and the clotting time was measured using Amelung
KC-4A Micro Coagulation Analyzer at 37◦C.
2.5. Conﬁrmation of Complementary DNA and Au-TBA
Hybridization. Au-TBA (100nM), 20-mer complementary
DNA (100nM), and thrombin (13.5nM) were incubated
for 30s at room temperature in 50mM Tris-HCl (pH 8.0),
100mM NaCl, 5mM KCl, and some of these samples were
irradiated by RFMF (1GHz, 1.5W) for 5min by using the
HP 8648C RF signal generator. After the RFMF irradiation,
we carried out native polyacrylamide gel electrophoresis
(PAGE)using11%polyacrylamide gelinTBEbuﬀer(89mM
Tris, 89 mM H3BO3,2 m ME D T A )a tr o o mt e m p e r a t u r e .
The ﬂuorescence intensities of complementary DNA were
analyzed by a Typhoon 8600.
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Figure 3: Evaluation of the eﬀect of complementary DNA on TBA
inhibitoryactivity.14–17-mer,20-mer,and23-mercomplementary
DNA (100nM) were incubated with Au-TBA (100nM). The white
bar shows the clotting time of thrombin and Au-TBA. The gray
bar shows the clotting time of thrombin, Au-TBA, and each
complementary DNA strand. Each clotting time represents the
average of the clotting times in two experiments, and error bars are
given.
3. Results and Discussion
First, we designed Au-TBA that has RFMF-controllable
inhibitory activity. We selected a 31-mer TBA as a model
aptamer. The 31-mer TBA forms a G-quadruplex-type
structure that is 15-mer TBA attached to 3 base loops
and a 5-bp stem. The internal loop region of the G-
quadruplex recognizes the thrombin [11]. The stem region
wouldstabilizetheG-quadruplexstructureandthusincrease
inhibitory activity. We then selected the 5  terminal of
the aptamer for conjugation with gold nanoparticles and
preparedAu-TBAusingamonomaleimidegoldnanoparticle
and 5  thiol-modiﬁed TBA. We expected that the gold
nanoparticle would not have an eﬀect on the TBA inhibitory
activity; further, heating of the gold nanoparticles by RFMF
irradiation destabilizes the stem structure of the aptamer,
resulting in a decrease in its inhibitory activity. In fact, the
prepared Au-TBA shows inhibitory activity similar to that
shown by unmodiﬁed TBA. Conjugation of the 5  terminal
of TBA with gold nanoparticles did not signiﬁcantly aﬀect
TBA function (data not shown).4 Journal of Nucleic Acids
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Figure 4: The control of the function of Au-aptamer by RFMF.
The white bar termed “RFMF oﬀ” shows the clotting time of the
mixture after 5min of incubation at room temperature. The black
bar termed “RFMF on” shows the clotting time of the mixture of
thrombin, ﬁbrinogen, TBA, and 20-mer complementary DNA after
5min of irradiation using RFMF. Each clotting time represents the
average of the clotting times in two experiments, and error bars are
given.
Because the heat generated from nanoparticles by RFMF
irradiation depends on nanoparticle size and magnetic ﬁeld
frequency, larger gold nanoparticles possibly aﬀect not only
the structure of the aptamer, but also thrombin structure.
To control aptamer function, we have to select a suitable
nanoparticle size and a magnetic ﬁeld frequency that do not
produce an unexpected eﬀect on enzyme activity. Then, we
selected gold nanoparticles with a diameter of 1.4nm, which
is the same as that of nanoparticles used in the study of
Hamad-Schﬀeril et al. [7]. They mentioned that the eﬀect
of heat induced by this nanoparticle, because 1GHz RFMF
irradiation was limited to proximity. To evaluate the eﬀect of
RFMF irradiation on thrombin activity, RFMF was used to
irradiate a mixture of Au-TBA and thrombin, and thrombin
activity was measured after RFMF irradiation. DNA can
easily refold to its correct structure, but it is diﬃcult for pro-
teins to renature correctly. A similar level of inhibition was
observed regardless of whether the mixture was irradiated
with RFMF (Figure 2). This indicates that heating induced
by RFMF irradiation did not aﬀect thrombin activity.
However, it is diﬃcult to evaluate thrombin activity
upon RFMF irradiation, because a complicated instrument
is required for the measurement of thrombin activity with
RFMF irradiation. Then, we used a complementary DNA
strandofTBA.WeexpectedRFMFwouldenhancehybridiza-
tion between Au-TBA and a complementary DNA strand.
The complementary DNA strand would repress refolding
of the aptamer to its functional structure after RFMF
irradiation, after which one can easily evaluate Au-TBA
inhibitory activity. We selected an optimal complementary
DNA strand that insigniﬁcantly aﬀects the Au-TBA structure
without RFMF irradiation.
First, we investigated the optimal length of the com-
plementary DNA strand for the evaluation of this system.
Because the complementary DNA strand should have a Tm
value lower than that of TBA (64◦C) [12], we designed 14–
17-mer,20-mer,and23-merDNAstrandscomplementaryto
the 3  terminal region of TBA; the 14–20-mer was designed
such that its Tm value was lower than that predicted for
TBA (Table 1)[ 13]. When we incubated a 14–17-mer or
20-mer complementary DNA with Au-TBA, they did not
signiﬁcantly aﬀect the inhibitory activity of TBA without
RFMF irradiation (Figure 3). On the other hand, the 23-mer
complementary DNA decreased the inhibitory activity of
TBA.Wethenselecteda20-mercomplementaryDNAstrand
to evaluate the eﬀect of RFMF on the inhibitory activity of
TBA.
We evaluated the controlling of TBA inhibitory activity
by RFMF irradiation. We mixed thrombin, Au-TBA, and
100-nM 20-mer complementary DNA and incubated these
at room temperature for 30s; this mixture was subse-
quently subjected to RFMF irradiation for 5min (Figure 4).
Then, we added ﬁbrinogen and measured the clotting
time. The thrombin solution containing Au-TBA and 20-
mer complementary DNA showed a shorter clotting time
after RFMF irradiation than after incubation for 5min at
room temperature without RFMF irradiation (Figure 4). We
observed a decrease of about 20% in the inhibitory activity
of TBA by RFMF irradiation.
In order to conﬁrm the successful hybridization of com-
plementary DNA and Au-TBA, we performed native PAGE
using ﬂuorescein-modiﬁed complementary DNA (FcDNA).
Because the gold nanoparticles quench the ﬂuorescence of
some ﬂuorescent molecules and the TBA was labeled with
a gold nanoparticle, it was diﬃcult to obtain a distinct
ﬂuorescence band indicating the formation of complex of
Au-TBA and 20-mer complementary DNA. Therefore, we
quantiﬁed the hybridization reaction by comparing the
ﬂuorescenceintensityoffreeFcDNA.Weobservedadecrease
in the ﬂuorescence intensity when Au-TBA was mixed with
FcDNA (Figure 5(a), lane 2) rather than when FcDNA was
used alone (Figure 5(a), lane 1) after RFMF irradiation.
Although this decrease was also observed without RFMF
(Figure 5(a), lane 3), we observed a weaker ﬂuorescence
intensity for free FcDNA subjected to RFMF irradiation than
FcDNA that was not subjected to the same. The ratio of
decrease in ﬂuorescence intensity was approximately 20%
(Figure 5(b)), and it shows good agreement with inhibitory
activity results. These results indicate that RFMF irradiation
destabilizes the Au-TBA structure and results in acceleration
of hybridization between a complementary DNA strand
and Au-TBA. We can say that we were able to control the
inhibitory activity of TBA with complementary DNA and
RFMF irradiation.
RFMFirradiation mightinduceheatingofAunanoparti-
cle resulting in destabilization of Au-TBA structure. During
RFMF irradiation, hybridization of complementary DNA
with Au-TBA might compete with refolding to native struc-
ture of Au-TBA. Since RFMF irradiation would be limitedJournal of Nucleic Acids 5
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Figure 5: The conﬁrmation of hybridization between FcDNA and Au-TBA by native PAGE. (a) Lane 1 shows a ﬂuorescence image of 20-
mer FcDNA. Lane 2 shows a ﬂuorescence image of FcDNA with thrombin and Au-TBA after RFMF irradiation. Lane 3 shows a ﬂuorescence
image of FcDNA with thrombin and Au-TBA after incubation for 5min at room temperature. (b) Signal intensity of FcDNA of Lane 2 and
3n o r m a l i z e dt oL a n e2 .
to local area around Au nanoparticle, induced heating of Au
nanoparticle would not have so much eﬀect on the solution
temperature. Therefore, free Au-TBA might refold to native
structure, whereas duplex might keep their structures after
RFMFirradiation.Additionally,complementaryDNAstrand
concentration would aﬀect hybridization eﬃciency. There-
fore, the control of structure of Au-TBA would be improved
by adjusting of RFMF irradiation time and complementary
DNA strand concentration.
In order to apply this system in therapeutic medicine,
we should be able to control aptamer function by RFMF
without the need for a complementary DNA strand. Because
RFMF irradiation would destabilize the aptamer structure,
the function of the aptamer is possibly repressed by RFMF
irradiation in the absence of a complementary DNA strand.
ItmaynotbeeasytodeterminetheexacteﬀectofRFMFirra-
diation on the aptamer function without a complementary
DNA strand, but we can control it by adjusting the RFMF
frequency and size of the gold nanoparticle, because the
extent of instability of the structure of the gold nanoparticle-
conjugated aptamer would depend on the energy generated
from the gold nanoparticle after RFMF irradiation.
Control of aptamer function by RFMF irradiation has
the following 3 advantages over that by UV light irradiation:
in vivo penetration, no DNA damage, and limited eﬀect
on conjugated DNA. Although there are many reports
describing the remote control of aptamers by UV light, deep
tissue penetration is diﬃcult and limits their application
in vitro or requires two-photon absorption, which can be
achieved only by a speciﬁc device. On the other hand,
because RFMF can penetrate deep tissues, its application
is not limited to an in vitro setting and can also be used
in vivo. In addition, because the eﬀect of heating induced
by gold nanoparticles irradiated by RFMF is limited to the
structure of the aptamer conjugated with gold nanoparticles,
theheatingofgoldnanoparticlesbreaksthetertiarystructure
of the aptamer but does not modify its chemical structure. In
addition, the heating of an Au nanoparticle can be limited to
a local region by adjusting the frequency of RFMF and size
of the gold nanoparticle [7]. Therefore, RFMF irradiation
prevents the unexpected eﬀect caused by DNA damage and
excessive heating of gold nanoparticles.
4. Conclusions
When therapeutic medicine produces an unexpected eﬀect,
it becomes necessary to control therapeutic medicine.
Although antidotes based on complementary DNA have
been developed for the use of therapeutic aptamers [14],
remote control in therapeutic medicine is an attractive
strategy. RFMF is widely used for magnetic resonance
imaging and photothermal therapy [15, 16]. Therefore,
heating induced by gold nanoparticles irradiated by RFMF
is an attractive option for controlling aptamer function
remotely in vivo. In this study, we demonstrated the control
of thrombin inhibitory activity of TBA by RFMF irradiation
and the use of using complementary DNA. Although we
should develop a control system that does not require com-
plementary DNA, we expect that the controlling of aptamer
function by RFMF would be a useful tool in the future.
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